Welcome to our dedicated page for PROGRESSIVE CARE news (Ticker: RXMD), a resource for investors and traders seeking the latest updates and insights on PROGRESSIVE CARE stock.
Progressive Care, Inc., through its subsidiaries Smart Medical Alliance, Inc. and PharmCo, LLC, is a South Florida health services organization providing administration, practice management, tele-pharmco, utilization management, quality assurance, EHR implementation, billing and coding, health practice risk management, prescription pharmaceuticals, compounded medications, anti-retroviral medications, MTM, and prescription medications to long-term care facilities.
Progressive Care Inc. (OTCQB: RXMD) reported its financial results for the year ending December 31, 2022, showing a 5% revenue increase to $40.6 million. Key highlights include a 7% rise in prescription revenue to $36.3 million and a $1.0 million increase in 340B contract revenue. However, gross profit margin decreased from 26% to 24%, primarily due to reduced COVID-19 testing revenue. The net loss expanded to $5.9 million, influenced by non-recurring expenses. The company successfully raised $5.4 million in capital and reduced convertible debt interest rates from 10% to 5%.
FAQ
What is the current stock price of PROGRESSIVE CARE (RXMD)?
What is the market cap of PROGRESSIVE CARE (RXMD)?
What services does Progressive Care, Inc. offer?
What are the subsidiaries of Progressive Care, Inc.?
What regions does Progressive Care, Inc. operate in?
When did Progressive Care, Inc. become a subsidiary of NextPlat Corp?
What are the key financial highlights of Progressive Care, Inc.?